DEC 12, 2018 4:41 PM PST

The Structure of Immunity

WRITTEN BY: Nicholas Breehl

When developing a new therapeutic approach to any disease, one way to begin is by determining the structure of the molecule or organism you are working with. The knowledge of physical characteristics provides opportunities for areas to focus on such as binding sites that can be inhibited. For this reason, a team of scientists works to build the atomic structure of an important immune system regulator.

In recent publishing of the online journal known as Scientific Report, a group of researchers from Brigham and Women’s Hospital describes the biophysical and structural characteristics of an immune regulating protein called human T cell immunoglobulin and mucin domain-containing protein-3 (hTIM-3).

The scientists hope that revealing the structure of hTIM-3 will provide new ideas for targeting the protein in diseases such as cancer and autoimmune disorders.

By making use of high-resolution X-ray crystallography and nuclear magnetic resonance imaging, the team can visualize hTIM-3 IgV domain and how it is involved with CEACAM1 – an immune evading mechanism for cancer.

X-ray crystallography is a technique for determining the three-dimensional structure of molecules, including complex biological macromolecules such as proteins and nucleic acids. It is a powerful tool in the elucidation of the three-dimensional structure of a molecule at atomic resolution. Diffracting X-rays collect data from a single crystal, which has an ordered, regularly repeating arrangement of atoms. Based on the diffraction pattern obtained from X-ray scattering off the periodic assembly of molecules or particles in the crystal, the electron density can be reconstructed.

Nuclear Magnetic resonance is described as selective absorption of very high-frequency radio waves by specific atomic nuclei that are subjected to an appropriately strong stationary magnetic field.

"The hTIM-3 protein is an important immune regulator, yet it has been difficult to target for drug development as high-resolution structure conformational details have been elusive," said senior author Richard Blumberg, MD, chief of the Division of Gastroenterology, Hepatology, and Endoscopy in the Department of Medicine at the Brigham. "We resolved the structure of hTIM-3 and established a novel biochemical assay to define its functionality, which will be useful for understanding the role of hTIM-3 in the immune system."

"This is the first NMR analysis of any immune-related TIM molecule and the first high-resolution structural report of the hTIM-3 IgV domain with association of critical co-factors such as calcium," said author Amit Gandhi, Ph.D., a researcher in Blumberg's laboratory in the Department of Medicine. "No one has been able to do this before. Hopefully, this will help with the targeting of human hTIM-3 and the development of useful therapeutics."

The team shares that the information collected will allow for an understanding of specific binding regions of the protein that therapeutic drugs can manipulate.

Sources: Scientific Reports, Science Direct, Science Daily, YouTube

 

About the Author
You May Also Like
JUN 06, 2020
Immunology
Cancer Cell Clusters Better At Resisting the Immune System
JUN 06, 2020
Cancer Cell Clusters Better At Resisting the Immune System
For cancerous cells in the body, it seems there is safety in numbers. Researchers from a newly published study investiga ...
JUN 14, 2020
Microbiology
Amping Up Immunity to Respiratory Viruses by Targeting Memory T Cells in the Lungs
JUN 14, 2020
Amping Up Immunity to Respiratory Viruses by Targeting Memory T Cells in the Lungs
It's easier than thought to activate immune cells that reside in the lungs and are involved in long-term immunity. Image ...
JUN 15, 2020
Drug Discovery & Development
New Antibiotic 'Irresistin' Defeats All Resistant Bacteria
JUN 15, 2020
New Antibiotic 'Irresistin' Defeats All Resistant Bacteria
Researchers from Princeton University have identified a compound capable of killing both Gram-positive and Gram-negative ...
JUL 14, 2020
Immunology
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
JUL 14, 2020
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
Scientists are working on developing an arsenal of nano-sized weapons in the war against COVID-19. These molecules, call ...
JUL 13, 2020
Drug Discovery & Development
Russia Completes First Human Trial for COVID-19 Vaccine
JUL 13, 2020
Russia Completes First Human Trial for COVID-19 Vaccine
The Sechenov University Center for Clinical Research in Moscow, Russia, has completed its first round of clinical trials ...
JUL 30, 2020
Immunology
Sunshine Could Lower Your Risk of Developing MS
JUL 30, 2020
Sunshine Could Lower Your Risk of Developing MS
In multiple sclerosis, or MS, the insulating sheaths around nerve cells in the brain and spinal cord called myelin becom ...
Loading Comments...